Retension Pharmaceuticals, Inc. (RTSN)
Nasdaq: RTSN · CIK 0002002988 · United States
Every official Retension Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RTSN filings
Retension Pharmaceuticals, Inc. documents
- Retension Pharmaceuticals, Inc. 10-K 2026RTSN 10-K 2026: annual report for fiscal 2026
- Retension Pharmaceuticals, Inc. 10-K 2025RTSN 10-K 2025: annual report for fiscal 2025
- Retension Pharmaceuticals, Inc. 10-K 2024RTSN 10-K 2024: annual report for fiscal 2024
- Retension Pharmaceuticals, Inc. 10-K 2023RTSN 10-K 2023: annual report for fiscal 2023
- Retension Pharmaceuticals, Inc. 10-K 2022RTSN 10-K 2022: annual report for fiscal 2022
- Retension Pharmaceuticals, Inc. 10-Q 2026RTSN 10-Q 2026: quarterly report for fiscal 2026
- Retension Pharmaceuticals, Inc. 10-Q 2025RTSN 10-Q 2025: quarterly report for fiscal 2025
- Retension Pharmaceuticals, Inc. 10-Q 2024RTSN 10-Q 2024: quarterly report for fiscal 2024
- Retension Pharmaceuticals, Inc. 10-Q 2023RTSN 10-Q 2023: quarterly report for fiscal 2023
- Retension Pharmaceuticals, Inc. 10-Q 2022RTSN 10-Q 2022: quarterly report for fiscal 2022
- Retension Pharmaceuticals, Inc. 8-K 2026RTSN 8-K 2026: current report for fiscal 2026
- Retension Pharmaceuticals, Inc. 8-K 2025RTSN 8-K 2025: current report for fiscal 2025
- Retension Pharmaceuticals, Inc. 8-K 2024RTSN 8-K 2024: current report for fiscal 2024
- Retension Pharmaceuticals, Inc. 8-K 2023RTSN 8-K 2023: current report for fiscal 2023
- Retension Pharmaceuticals, Inc. 8-K 2022RTSN 8-K 2022: current report for fiscal 2022
- Retension Pharmaceuticals, Inc. DEF 14A 2026RTSN DEF 14A 2026: proxy statement for fiscal 2026
- Retension Pharmaceuticals, Inc. DEF 14A 2025RTSN DEF 14A 2025: proxy statement for fiscal 2025
- Retension Pharmaceuticals, Inc. DEF 14A 2024RTSN DEF 14A 2024: proxy statement for fiscal 2024
- Retension Pharmaceuticals, Inc. DEF 14A 2023RTSN DEF 14A 2023: proxy statement for fiscal 2023
- Retension Pharmaceuticals, Inc. DEF 14A 2022RTSN DEF 14A 2022: proxy statement for fiscal 2022
- Retension Pharmaceuticals, Inc. Form 4 2026RTSN Form 4 2026: insider trading filing for fiscal 2026
- Retension Pharmaceuticals, Inc. Form 4 2025RTSN Form 4 2025: insider trading filing for fiscal 2025
- Retension Pharmaceuticals, Inc. Form 4 2024RTSN Form 4 2024: insider trading filing for fiscal 2024
- Retension Pharmaceuticals, Inc. Form 4 2023RTSN Form 4 2023: insider trading filing for fiscal 2023
- Retension Pharmaceuticals, Inc. Form 4 2022RTSN Form 4 2022: insider trading filing for fiscal 2022
- Retension Pharmaceuticals, Inc. S-1 2026RTSN S-1 2026: registration statement for fiscal 2026
- Retension Pharmaceuticals, Inc. S-1 2025RTSN S-1 2025: registration statement for fiscal 2025
- Retension Pharmaceuticals, Inc. S-1 2024RTSN S-1 2024: registration statement for fiscal 2024
- Retension Pharmaceuticals, Inc. S-1 2023RTSN S-1 2023: registration statement for fiscal 2023
- Retension Pharmaceuticals, Inc. S-1 2022RTSN S-1 2022: registration statement for fiscal 2022
- Retension Pharmaceuticals, Inc. 13F 2026RTSN 13F 2026: institutional holdings for fiscal 2026
- Retension Pharmaceuticals, Inc. 13F 2025RTSN 13F 2025: institutional holdings for fiscal 2025
- Retension Pharmaceuticals, Inc. 13F 2024RTSN 13F 2024: institutional holdings for fiscal 2024
- Retension Pharmaceuticals, Inc. 13F 2023RTSN 13F 2023: institutional holdings for fiscal 2023
- Retension Pharmaceuticals, Inc. 13F 2022RTSN 13F 2022: institutional holdings for fiscal 2022
More companies